Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Enpatoran · M-5049

Small molecule · Antagonist of Toll-like receptor 7 (TLR7) and Toll-like receptor 8 (TLR8) · developed by Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Phase 3 Most advanced trial
MRK Developer

What is Enpatoran?

Enpatoran is an orally bioavailable dual antagonist of Toll-like receptors 7 and 8, binding and inhibiting TLR7/8-mediated signaling that drives pro-inflammatory cytokine production. It is being studied in systemic lupus erythematosus and cutaneous lupus erythematosus.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
M-5049
Drug type
Small molecule
Targets
Toll-like receptor 7 (TLR7), Toll-like receptor 8 (TLR8)
Mechanism
Antagonist of Toll-like receptor 7 (TLR7) and Toll-like receptor 8 (TLR8)
Pathways
TLR7/8-mediated innate immune signaling, pro-inflammatory cytokine production
Therapy area
Immunology
Developer
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (MRK)
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 3
UNII
7CZ390V26X

Conditions studied

Cutaneous Lupus ErythematosusSystematic Lupus Erythematosus

Other drugs acting on TLR7 / TLR8

More from Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Sources

Updated Nov 8, 2026. Something wrong or missing? Report it on the MRK page.

Follow MRK, the company behind Enpatoran

See MRK's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

MRK catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.